A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity

Zakuan Zainy Deris(Monash University), Jesmin Akter(Monash University), Sivashangarie Sivanesan(Monash University), Kade D. Roberts(Monash University), Philip E. Thompson(Monash University), Roger L. Nation(Monash University), Jian Li(Monash University), Tony Velkov(Monash University)

The Journal of Antibiotics

October 30, 2013

10.1038/ja.2013.111

Cited by 216Open Access

Abstract

Related Papers

The challenge of new drug discovery for tuberculosis

Anil Koul, Éric Arnoult, Nacer Lounis et al.|Nature|2011|1k

Structure−Activity Relationships of Polymyxin Antibiotics

Tony Velkov, Philip E. Thompson, Roger L. Nation et al.|Journal of Medicinal Chemistry|2009|766

Heteroresistance to Colistin in Multidrug-Resistant <i>Acinetobacter baumannii</i>

Jian Li, Craig R. Rayner, Roger L. Nation et al.|Antimicrobial Agents and Chemotherapy|2006|541

Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs

Edward A. Weinstein, Takahiro Yano, Linsheng Li et al.|Proceedings of the National Academy of Sciences|2005|293

The Proton-Translocating NADH−Quinone Oxidoreductase in the Respiratory Chain: The Secret Unlocked

Takao Yagi, Akemi Matsuno‐Yagi|Biochemistry|2003|288